News
Class 2 Medicines Recall: Bristol Laboratories Limited, Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP, EL(26)A/33
Source: MHRA 09.07.2026 Bristol Laboratories Limited is recalling one batch (7124002) of Phenoxymethylpenicillin 250 mg/5 ml Oral Solution Sugar Free due to product labelling issues. DMRC reference number DMRC-40025785 Marketing...
FREE CPD Educational Resources
We are pleased to offer Gazette readers FREE CPD Educational Resources. Our new concise modules outline and reinforce best practices, offering an easy and quick way to enhance your...
UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31
Source: MHRA 30.06.2026 – Updated 07.07.2026 Relonchem Limited have informed the MHRA that particles have been observed inside some bottles of Gabapentin Relonchem Oral Solution, identified through a customer complaint....
Turning Expertise into Measurable Results
Dispensary Profitability Review When a practice in Newbury wanted to improve the profitability of its dispensary, they turned to Dispex for a Profitability Review. Like many practices, they wanted to...
Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32
Source: MHRA 30.06.2026 Flamingo Pharma UK Ltd have informed the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect PIL. The affected packs contain the PIL for...
Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31
Source: MHRA 30.06.2026 Relonchem Limited have informed the MHRA that particles have been observed inside some bottles of Gabapentin Relonchem Oral Solution, identified through a customer complaint. DMRC reference number...
The Categories
Updates and Insights Our members can access our Category H Updates page. At the bottom of the Category H Update page we have published Dispex Insights (A members- only resource), using...
Class 4 Medicines Defect Notification: Brancaster Pharma Limited, Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection, EL(26)A/30
Source: MHRA 29.06.2026 Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were released with an...
Planning for Summer holidays and staff shortages in your Dispensary
By Kirstye Todd- Dispex Consultant As summer approaches, dispensary staff are likely to be requesting time off for their holidays. Managing absences can be a significant challenge. Without proper planning,...
Dispex Live 2026 – Final Programme Announced
With less than an a week to go, please see the final seminar programme here. Also check out our latest Gazette covering Everything You Need to Know! Registration closing soon – secure your...
Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL(26)A/29
Source: MHRA 16.06.26 Orbit Pharma Limited is recalling a specific batch of Cyclizine Lactate 50 mg/ml Solution for injection as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies...
Category H June 2026
